EDIT
Editas Medicine Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$2.44
-0.10 ▼ -3.94%
🌙 3월 13일 7:39 PM ET (한국 3/14 08:39)
$2.50
+0.06 ▲ +2.30%
| Index | RUT | P/E | - | EPS (ttm) | -1.88 | Insider Own | 0.52% | Shs Outstand | 0.10B | Perf Week | 22% |
| Market Cap | 0.24B | Forward P/E | - | EPS next Y | 8.84% | Insider Trans | -2.56% | Shs Float | 0.10B | Perf Month | 37.85% |
| Enterprise Value | 0.17B | PEG | - | EPS next Q | -0.27 | Inst Own | 52.36% | Short Float | 12.21% | Perf Quarter | -6.15% |
| Income | -0.16B | P/S | 5.89 | EPS this Y | 37.16% | Inst Trans | 7.62% | Short Ratio | 6.4 | Perf Half Y | -9.96% |
| Sales | 0.04B | P/B | 8.75 | EPS next 5Y | 15.6% | ROA | -60.61% | Short Interest | 11.89M | Perf YTD | 19.02% |
| Book/sh | 0.28 | P/C | 1.63 | EPS past 3/5Y | 17.49% 1.84% | ROE | -198.14% | 52W High | -46.22% ($4.54) | Perf Year | 78.1% |
| Cash/sh | 1.5 | P/FCF | - | Sales past 3/5Y | 27.15% -14.89% | ROIC | -172.17% | 52W Low | 168.1% ($0.91) | Perf 3Y | -71.06% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 34.67% | Gross Margin | 86.98% | Volatility(W/M) | 12.85% 9.83% | Perf 5Y | -94.73% |
| Dividend TTM | - | EV/Sales | 4.17 | Sales Y/Y TTM | 25.4% | Oper. Margin | -245.15% | ATR (14) | 0.21 | Perf 10Y | -92.19% |
| Dividend Ex-Date | - | Quick Ratio | 3.54 | EPS Q/Q | 89.53% | Profit Margin | -395.01% | RSI (14) | 59.08 | Recom | 2.11 |
| Dividend Gr. 3/5Y | - | Current Ratio | 3.54 | Sales Q/Q | -19.16% | SMA20 | 15.63% ($2.11) | Beta | 2.1 | Target Price | $3.85 |
| Payout | - | Debt/Eq | 2.81 | Earnings | 3000000 | SMA50 | 18.6% ($2.06) | Rel Volume | 0.66 | Prev Close | $2.54 |
| Employees | 87 | LT Debt/Eq | 2.41 | EPS/Sales Surpr. | 74.2% 196.33% | SMA200 | -4.5% ($2.55) | Avg Volume(3M) | 1.86M | Price | $2.44 |
| IPO | 2016/2/3 | Option/Short | Yes/Yes | Trades | 5202 | Volume | 1,218,582 | Change | -3.94% |
뉴스 로딩 중...